Viral vaccine

  • From 1962 to 2005, a whole-virus, inactivated trivalent influenza vaccine was produced.
  • In 2005, the reconstruction of the facility according to cGMP standards began.
  • In 2009, the Torlak Institute became part of the WHO Global Action Plan.
  • 2020: TorVaxFlu® – Influenza vaccine (fragmented virus, inactivated).

The TorVaxFlu® vaccine is intended for protection against influenza in adults aged 18 and older.

Bacterial vaccines

Monovalent vaccines

TETAVAXAL-T® – Tetanus vaccine, adsorbed

BCG vaccine, lyophilized – Tuberculosis vaccine

Polyvalent vaccines

DITEVAXAL-T® – Tetanus and Diphtheria vaccine, adsorbed

DITEVAXAL-T® for adults – Tetanus and Diphtheria vaccine, adsorbed

ALDIPETE-T® – Pertussis, Diphtheria, and Tetanus vaccine, adsorbed